Lady Prelox® improves sexual function in post-menopausal women

Area of Science:

• Reproductive Health
• Nutritional Science
• Clinical Trials

Background:

• Menopause is associated with changes in sexual function.
• Dietary supplements are being explored for managing menopausal symptoms.
• The Female Sexual Function Index (FSFI) is a key measure for assessing sexual health.

Purpose of the Study:

• To evaluate the efficacy of Lady Prelox®, a proprietary dietary supplement.
• To assess improvements in sexual function among post-menopausal women.
• To compare the effects of Lady Prelox® against a placebo control.

Main Methods:

• A single-blinded, pilot study design was employed.
• Participants were post-menopausal women with moderate sexual function impairment.
• The study involved a treatment group (Lady Prelox®) and a placebo control group, with assessments over eight weeks.

Main Results:

• Lady Prelox® significantly increased total FSFI scores after four and eight weeks.
• The supplement showed comparative efficacy over placebo (P<0.05).
• All six FSFI domains (desire, arousal, lubrication, orgasm, satisfaction, pain) showed positive responses to Lady Prelox® without significant adverse effects.

Conclusions:

• Lady Prelox® presents a promising treatment option for women with impaired sexual function.
• Further research with larger cohorts, including pre- and perimenopausal women, is recommended.
• The study highlights a potential non-hormonal approach to improving post-menopausal sexual health.